Search Results

Cognitive impairment in Sjogren's syndrome: Interplay between BACE1 activity, inflammatory blood biomarkers and neurocognitive testing.

• Authors : Kooshki, Alireza¹ (AUTHOR); Yousefi, Mohammad¹ (AUTHOR); Farmani, Reyhane¹ (AUTHOR)

Subjects: *Sjogren's syndrome; *Cognition disorders; *Inflammatory mediators

• Source: PLoS ONE. 8/1/2025, Vol. 20 Issue 8, p1-21. 21p.

Record details

Potential Novel Tissue Biomarkers in Salivary Glands of Patients with Sjogren's Syndrome.

• Authors : Sadullahoglu, Canan¹ (AUTHOR); Yaprak, Neslihan² (AUTHOR) ; Yazısız, Veli³ (AUTHOR)

• Source: Journal of Clinical Medicine. Apr2025, Vol. 14 Issue 7, p2390. 10p.

Record details

Levocarnitine for Dry Eye in Sjogren's Syndrome

• Authors : Christine Shieh, Assistant Professor of Ophthalmology

• Source: A Randomized Placebo-controlled, Double Blind Pilot Crossover Trial of Levocarnitine for the Treatment of Keratoconjunctivitis Sicca in Sjogren's

Record details

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-1)

• Source: A Randomized, Double-blind, Placebo Controlled, 2-arm Multicenter Phase 3 Study to Assess the Efficacy and Safety of Ianalumab in Patients With Active Sjogren's

Record details

Catalpol regulates expression of lnc-N0NHSAT071210 in salivary gland epithelial cells for therapy mechanism of Sjogren's syndrome model mice.

• Authors : HE Weiqian¹; WU Chunfeng²; LI Xiaofen¹

• Source: Chinese Journal of Immunology. Apr2025, Vol. 41 Issue 4, p798-802. 5p.

Record details

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

• Source: A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HZN-1116 in Participants With Sjögren's Syndrome

Record details

Oral Manifestations of Primary Sjogren’s Syndrome with an Interdisciplinary Management Approach – A Case Report

• Authors : Sadaksharam Jayachandran; M Archana

Subjects: transcutaneous electrical nerve stimulation; Medicine; autoimmune disease

• Source: Medical Journal of Dr. D.Y. Patil Vidyapeeth, Vol 18, Iss 2, Pp 333-337 (2025)

Record details

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-2)

• Source: A Randomized, Double-blind, Placebo Controlled, 3-arm Multicenter Phase 3 Study to Assess the Efficacy and Safety of Ianalumab in Patients With Active Sjogren's

Record details

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

• Source: A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Nipocalimab in Adults With Primary Sjogren's

Record details

Wheat-free Diet in the Treatment of Sjogren's Syndrome

• Authors : Aurelio Seidita; Pasquale Mansueto, Associate Professor

• Source: Efficacy of a Wheat-free Diet in Autoimmune Diseases: a Pilot Therapeutic Study in Sjogren's DiseaseCarroccio A, Giambalvo O, Blasca F, Iacobucci R, D'Alcamo A,

Record details